Clinical trial
A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to…
NCT00214266 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00214266 |
|---|---|
| Title | A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to Allow for a Calcineurin Inhibitor Free Regimen After Renal Transplantation |
| Official title | A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to Allow for a Calcineurin Inhibitor Free Regimen After Renal Transplantation |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Renal Transplantation |
| Intervention type | Drug |
| Interventions | Campath 1H®, Rituximab, mycophenolate mofetil |
| Enrollment | 31 |
| Start date | Jan 1, 2005 |
| Primary completion | Aug 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | May 30, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: